First Command Advisory Services’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
First Command Advisory Services's PTGX Position: Q3 2026 in Review
First Command Advisory Services opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 3 shares worth $423. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings.
380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- First Command Advisory Services held 3 shares of Protagonist Therapeutics worth $423 as of Q3 2026.
- Protagonist Therapeutics was a new First Command Advisory Services position in Q3 2026.
- Protagonist Therapeutics made up ﹤0.01% of First Command Advisory Services's portfolio in Q3 2026, its #1365 holding.
- 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on First Command Advisory Services's 13F filing for Q3 2026, filed 5 Nov 2026.